K

NATCO Pharmaceuticals logo

NATCO Pharmaceuticals

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series D

eGenesis logo
eGenesis

Biotechnology • Kidney transplants

Lux Capital logo
Parkwood Corporation logo
NATCO Pharmaceuticals logo
Khosla Ventures logo

eGenesis is a biotechnology company developing genetically engineered organs to address the global organ shortage, with a focus on advancing their lead product candidate for kidney transplants.

Series D
$191M
09/04/2024
Article